Health Problems

Drug trial seeking first ever treatment for dangerous side effect of Prader-Willi syndrome

One in every 15,000 children is affected by Prader-Willi syndrome (PWS), a complex, genetic endocrine condition caused by a disorder of chromosome 15. It’s non-inheritable, meaning the condition isn’t passed down from a family member. Among the regular side effects like growth hormone deficiency, hypothyroidism, delayed puberty, behavioral problems and learning difficulties, but hyperphagia is […]

Health Problems

‘Spin’ found in over half of clinical trial abstracts published in top psychiatry journals

‘Spin’—exaggerating the clinical significance of a particular treatment without the statistics to back it up—is apparent in more than half of clinical trial abstracts published in top psychology and psychiatry journals, finds a review of relevant research in BMJ Evidence Based Medicine. The findings raise concerns about the potential impact this might be having on […]

Health News

First randomised trial finds no substantial difference in risk of acquiring HIV for 3 different forms of contraception

Previous research has suggested that some contraceptive methods may increase women’s susceptibility to HIV. However, all three forms of contraception trialled were safe and highly effective, supporting their continued and increased access alongside high quality HIV prevention services. A randomised trial of more than 7,800 African women found that a type of contraceptive injection (intramuscular […]

Personal Health

Gene therapy for gamma-sarcoglycanopathy moves toward a clinical trial

Isabelle Richard’s team, a CNRS researcher in an Inserm unit at Genethon, the AFM-Telethon laboratory, has demonstrated the efficacy of gene therapy and determined the effective dose for treating a rare muscle disease, gamma-sarcoglycanopathy, in mouse models of the disease. Based on these encouraging results, published in Molecular Therapy: Methods and Clinical Development, the researchers […]

Health Problems

Favorable outcomes seen in long term for ALLR3 trial

(HealthDay)—For children with B-cell precursor acute lymphoblastic leukemia with late bone marrow relapse, risk stratification by minimal residual disease seems to be an effective strategy for treatment, according to a study recently published in The Lancet Haematology. Catriona Parker, Ph.D., from the University of Manchester in the United Kingdom, and colleagues conducted a long-term follow-up […]